Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kitahara, Maki, Sakamoto, M., Ike, M., Sakata, S., & Benno, Y. (2005). Bacteroides plebeius sp. nov. and Bacteroides coprocola sp. nov., isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology, 55(Pt 5), 2143–2147.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces
DNA G+C(%): 42.4
|
Opt. T: 37℃
Bile reaction(%): +
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
Acetate, Succinate |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R(16)
oxacillin: R(16)
piperacillin: Var(MIC50): 4), MIC90: Var(4
meropenem: S(0.19)
|
cefotaxime: Var(MIC50): 8), MIC90: Var(8
cefoxitin: Var(MIC50): 8), MIC90: Var(8
ceftazidime: R(128)
|
tobramycin: R(>1024)
|
azithromycin: S(0.75)
erythromycin: S(0.75)
clarithromycin: S(0.094)
spiramycin: S(0.25)
|
ciprofloxacin: S(1.5)
gatifloxacin: S(0.023)
moxifloxacin: S(0.1)
norfloxacin: Var(MIC50): 7), MIC90: Var(7
ofloxacin: S(0.5)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(0.25)
tigecycline: S(<0.016)
|
|
|
metronidazole: S(0.25)
sulfamethoxazole: R(>1024)
|
|